The three-year study followed 3,508 patients with stage I through III colon or rectal cancer who had undergone surgery.

Currently, about 50% of patients with locally advanced rectal cancer have an incomplete response to TNT. (1) TME is recommended to address the higher risks of local recurrence and distant metastasis.

Rectal cancer is a cancer deriving from abnormal cell growth in the lining or epithelium of the rectum. Rectal and colorectal tumours are genetically considered to be the same cancer. Rectal ...